These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18335887)

  • 1. [Liver transplantation: new organ allocation system in Switzerland].
    Fontana M; Giostra E; Pilon N; Michetti P; Mentha G; Pascual M; Moradpour D
    Rev Med Suisse; 2008 Jan; 4(141):221-3. PubMed ID: 18335887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory test variability and model for end-stage liver disease score calculation: effect on liver allocation and proposal for adjustment.
    Ravaioli M; Masetti M; Ridolfi L; Capelli M; Grazi GL; Venturoli N; Di Benedetto F; Bianchi FB; Cavrini G; Faenza S; Begliomini B; Pinna AD; Gerunda GE; Ballardini G
    Transplantation; 2007 Apr; 83(7):919-24. PubMed ID: 17460563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy.
    Heuman DM; Mihas AA; Habib A; Gilles HS; Stravitz RT; Sanyal AJ; Fisher RA
    Liver Transpl; 2007 Jan; 13(1):30-7. PubMed ID: 17154400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F; Coria SA; Boni R; Pereira LA
    Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers.
    Ravaioli M; Masetti M; Dazzi A; Romano A; Spaggiari M; Grazi GL; Ercolani G; Cescon M; Di Gioia P; De Ruvo N; Montalti R; Ballarin R; Di Benedetto F; Ridolfi L; Alvaro N; Ramacciato G; Morelli C; Gerunda E; Pinna AD
    Transplant Proc; 2008; 40(6):1814-5. PubMed ID: 18675057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liver transplantation].
    Samuel D; Antonini TM
    Rev Prat; 2007 Feb; 57(3):280-6. PubMed ID: 17578028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New organ allocation criteria and decreased mortality on liver transplant waiting list.
    Lang L
    Gastroenterology; 2008 Feb; 134(2):379-80. PubMed ID: 18242201
    [No Abstract]   [Full Text] [Related]  

  • 9. Organ allocation for chronic liver disease: model for end-stage liver disease and beyond.
    Asrani SK; Kim WR
    Curr Opin Gastroenterol; 2010 May; 26(3):209-13. PubMed ID: 20224394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card.
    Freeman RB
    Hepatology; 2008 Mar; 47(3):1052-7. PubMed ID: 18161047
    [No Abstract]   [Full Text] [Related]  

  • 12. Overview of the MELD score and the UNOS adult liver allocation system.
    Martin AP; Bartels M; Hauss J; Fangmann J
    Transplant Proc; 2007 Dec; 39(10):3169-74. PubMed ID: 18089345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.
    Weismüller TJ; Negm A; Becker T; Barg-Hock H; Klempnauer J; Manns MP; Strassburg CP
    Transpl Int; 2009 Oct; 22(10):970-8. PubMed ID: 19619170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MELD-based liver allocation: who is underserved?
    Biggins SW; Bambha K
    Semin Liver Dis; 2006 Aug; 26(3):211-20. PubMed ID: 16850370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival benefit after liver transplantation: a single European center experience.
    Ravaioli M; Grazi GL; Dazzi A; Bertuzzo V; Ercolani G; Cescon M; Cucchetti A; Masetti M; Ramacciato G; Pinna AD
    Transplantation; 2009 Sep; 88(6):826-34. PubMed ID: 19920783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In a MELD-based economy, how can we fight off inflation?
    Biggins SW; Feng S
    Liver Transpl; 2007 Jan; 13(1):2-4. PubMed ID: 17192889
    [No Abstract]   [Full Text] [Related]  

  • 17. MELD-based allocation scheme for liver transplantation in Israel.
    Onaca N; Mor E
    Isr Med Assoc J; 2006 Sep; 8(9):651-2. PubMed ID: 17058421
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged waiting times for liver transplantation in obese patients.
    Segev DL; Thompson RE; Locke JE; Simpkins CE; Thuluvath PJ; Montgomery RA; Maley WR
    Ann Surg; 2008 Nov; 248(5):863-70. PubMed ID: 18948816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process.
    Shechter SM; Bryce CL; Alagoz O; Kreke JE; Stahl JE; Schaefer AJ; Angus DC; Roberts MS
    Med Decis Making; 2005; 25(2):199-209. PubMed ID: 15800304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of disease severity and survival rates after liver transplantation in the United Kingdom, Canada, and the United States.
    Stell DA; McAlister VC; Thorburn D
    Liver Transpl; 2004 Jul; 10(7):898-902. PubMed ID: 15237374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.